Immune globulin subcutaneous, human 20% solution (Xembify®), a new high concentration immunoglobulin product for subcutaneous administration-Reference-Cited by-同舟云学术

Immune globulin subcutaneous, human 20% solution (Xembify®), a new high concentration immunoglobulin product for subcutaneous administration

Published:2020-03 Issue: Volume:64 Page:34-40
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Alonso William,Vandeberg Pete,Lang John,Yuziuk Jeffrey,Silverstein Rebecca,Stokes Kenya,McBride Dennis,Cruz Maria,Burns Doug,Merritt W. Keither,Willis Todd,Jorquera Juan I.

Funder

Grifols Bioscience Research Group

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference24 articles.

1. Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role;Bozzo;Expert Rev Anti Infect Ther,2017

2. Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route;Gardulf;BioDrugs,2007

3. Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose;Berger;Curr Opin Allergy Clin Immunol,2011

4. High concentration formulation feasibility of human immunoglobulin G for subcutaneous administration;Dani;J Pharm Sci,2007

5. Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography;Lebing;Vox Sanguinis,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protecting children and adults with primary antibody deficiencies against common and emergent pathogens and non-infectious complications;Clinical and Experimental Immunology;2024-07-16

2. Stability of Protein Pharmaceuticals: Recent Advances;Pharmaceutical Research;2024-06-27

3. Application of a Caprylate/Chromatography Purification Process for Production of a Hepatitis B Immune Globulin from Pooled Human Plasma;Plasmatology;2023-01

4. Impact of buffer concentration on the thermal stability of immunoglobulin G;Journal of Pharmaceutical Investigation;2022-07-26

5. Development of Improved High-Performance Liquid Chromatography Method for the Determination of Residual Caprylic Acid in Formulations of Human Immunoglobulins;Molecules;2022-03-03